Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: University of Freiburg, Novartis (Germany)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novartis Pharma
OpenAlex ID: W2075025181
